We are excited to share that @MBVanElzakker & team at @MGHMartinos have published a preprint with the results of a high-resolution #LongCovid imaging study. They identified neuroinflammation across a wide range of brain regions in LongCovid patients: polybio.org/polybio-suppor…
2/ They additionally found that #neuroinflammation positively correlated with blood measures related to vascular dysfunction. The study is supported via our LongCovid Research Consortium
3/ More specifically, the team used a neuroimaging method called position emission tomography (PET) to measure #neuroimmune activation in the brains of LongCovid study participants
4/ This neuroimmune activation can reflect activity of glial cells or #inflammatory activation of the brain’s blood vessels, both of which can be components of neuroinflammation
5/ As a group the #LongCovid patients had more of the PET signal demonstrating neuroinflammation when compared to healthy study participants
6/ Interestingly, this neuroinflammation was located in some #brain areas that are exposed to circulating blood factors via normal anatomical gaps in the specialized “blood-brain barrier” of the brain’s blood vessels
7/ This finding inspired the team to measure a selection of #vascular health-related factors in the blood of the #LongCovid study participants, which was collected immediately before their scans
8/ They found that seven vascular factors including fibrinogen and L-selection were significantly correlated with neuroinflammation in the #LongCovid group
9/ “This suggests that the neuroinflammation in #LongCovid patients may be connected to vascular problems” says Dr. VanElzakker
10/ Indeed other research teams have found #SARS-CoV-2 spike protein (derived from viral reservoirs) or microclots in LongCovid blood that might be reaching parts of the #brain and driving inflammation
11/ “A better understanding of these potential sources of neuroinflammation would be important for guiding related #treatments and clinical trials” says Hannah Bues, the study’s clinical research coordinator
12/ Dr. VanElzakker and team have several other studies underway to probe connections between #vascular damage, clotting, #immune activation, and #SARS-CoV-2 persistence in Long COVID, including extended analyses of their PET neuroimaging participants
13/ The team is also running a similar PET imaging study in patients with #ME/CFS, so that comparison of neuroinflammation and vascular factors between patients with the two related diagnoses can be compared
PolyBio is proud to have supported this new study by @MichaelPelusoMD & team. They identified tissue-based T cell activation in body sites such as brainstem/bone marrow + #SARS-CoV-2 RNA persistence in colorectal tissue up to 2 years post-COVID-19: medrxiv.org/content/10.110…
2/ More specifically they performed whole-body positron emission tomography (#PET) imaging in a group of 24 participants at time points ranging from 27-910 days following acute SARS-CoV-2 infection using a novel radiotracer that quantifies activated T lymphocytes
3/ Tracer uptake in the post-acute #COVID-19 group - which included participants with and without #LongCovid symptoms - was significantly higher compared to pre-pandemic controls in many anatomical regions
PolyBio is excited to be leading the LongCovid Research Consortium (LCRC): a global scientific collaboration to rapidly & comprehensively study #LongCovid disease mechanisms, with a focus on SARS-CoV-2 reservoir (). LCRC projects we are supporting include:polybio.org/longcovid
1. Perelman School of Medicine University of Pennsylvania: “Long COVID: Using #SARS-CoV-2 specific T cells as biosensors of viral persistence” 👉 Learn more here: polybio.org/projects/long-…
2. JCVI/Cardiff University/Karolinska Institutet: “Elucidation of SARS-CoV-2 reservoir and related Long COVID pathology in #lung tissue, fluid, and blood using molecular #virology & advanced sequencing” 👉 Learn more here: polybio.org/projects/eluci…
This is an important talk @resiapretorius gave at the @polybioRF Seminar Series. Her early pilot data (~10 subjects) shows that #LongCovid patients have abnormal microclots in their blood samples that are indicative of endothelial + platelet dysfunction:
2/ The microclots in the LongCovid samples contain serum amyloid A, fibrinogen, complement factors, and cytoskeletal kerratin. Dr. Pretorius has already filed a patent for diagnosing #LongCovid using detection of these deposits. She is also writing a paper on her findings.
3/ This is a cool image from her presentation that shows 1) the blood of a patient before #COVID-19 (healthy) 2) microclots in the patient’s #blood during COVID-19 3) microclots in the patient's blood several months later when they had #LongCovid symptoms